Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats
Endocrinology · 11.02.2023 · 164 (4)
DOI: 10.1210/endocr/bqad022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 31.01.2023. Verfasst von Tomoka Hasegawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, and Faculty of Dental Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Hyperparathyroidism, Secondary, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Kyowa Kirin Co., Ltd..
Abstract (Originalsprache)
To elucidate the effect of evocalcet, a new oral calcimimetic to bone of secondary hyperparathyroidism (SHPT) with chronic kidney disease (CKD), the rats were 5/6 nephrectomized and fed on a high-phosphate diet. The treated rats were then divided into vehicle groups and evocalcet administered groups. The rats in the vehicle groups exhibited increased levels of serum PTH and inorganic phosphate (Pi) levels, high bone turnover, and severe cortical porosity, mimicking SHPT (CKD-SHPT rats). The cortical bone of the CKD-SHPT rats showed broad demineralization around the osteocytes, suppression of Phex/small integrin-binding ligand N-linked glycoprotein-mediated mineralization in the periphery of the osteocytic lacunae, and increased levels of osteocytic cell death, all of which were considered as the first steps of cortical porosity. In contrast, evocalcet ameliorated the increased serum PTH levels, the enlarged osteocytic lacunae, and the cortical porosity of the CKD-SHPT rats. Osteocytes of CKD-SHPT rats strongly expressed PTH receptor and Pit1/Pit2, which sense extracellular Pi, indicating that PTH and Pi affected these osteocytes. Cell death of cultured osteocytes increased in a Pi concentration-dependent manner, and PTH administration rapidly elevated Pit1 expression and enhanced osteocytic death, indicating the possibility that the highly concentrated serum PTH and Pi cause severe perilacunar osteolysis and osteocytic cell death. It is likely therefore that evocalcet not only decreases serum PTH but also reduces the exacerbation combined with PTH and Pi to the demineralization of osteocytic lacunae and osteocytic cell death, thereby protecting cortical porosity in CKD-SHPT rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, and Faculty of Dental Medicine, Hokkaido University, Sapporo, Japan.
- Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan.
- Biomedical Science Research Laboratories 1, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Shizuoka, Japan.
ORCID-Profile: Norio Amizuka
Förderung
- Japan Society for the Promotion of Science
- Kyowa Kirin Co., Ltd.
Zitieren
APA
Hasegawa, T., Tokunaga, S., Yamamoto, T., Sakai, M., Hongo, H., Kawata, T., & Amizuka, N. (2023). Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats. Endocrinology, 164(4). https://doi.org/10.1210/endocr/bqad022
Vancouver
Hasegawa T, Tokunaga S, Yamamoto T, Sakai M, Hongo H, Kawata T, et al. Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats. Endocrinology. 2023;164(4). doi:10.1210/endocr/bqad022
BibTeX
@article{Hasegawa2023,
author = {Hasegawa, Tomoka and Tokunaga, Shin and Yamamoto, Tomomaya and Sakai, Mariko and Hongo, Hiromi and Kawata, Takehisa and Amizuka, Norio},
title = {Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats},
journal = {Endocrinology},
year = {2023},
volume = {164},
number = {4},
doi = {10.1210/endocr/bqad022}
}
EUVIMED